Status:
WITHDRAWN
Functional and Clinical Impact of CYP3A Genetic Polymorphisms on Statin Therapy
Lead Sponsor:
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Conditions:
Patients With High Cholesterol Levels Needing a Lipid-lowering Therapy
Eligibility:
All Genders
25-80 years
Brief Summary
Patients needing lipid lowering therapy will be recruited before initiation of the treatment. For each patient, total and LDL cholesterol levels before start of therapy will be measured. One, three an...
Eligibility Criteria
Inclusion
- Patient known to be compliant
- Age \[25-80\]
- treated with Atorvastatin, simvastatin, fluvastatin.
Exclusion
- Pregnancy
Key Trial Info
Start Date :
August 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2019
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01867203
Start Date
August 1 2017
End Date
September 1 2019
Last Update
March 18 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Saint-Luc Hospital
Brussels, Belgium, 1200